Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tjeerd S Aukema

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Clinical Colorectal Cancer|October 10, 2025
Incidence of Mismatch Repair Deficiency in Rectal Cancer and Response to Neoadjuvant TreatmentJelle A Nieuwstraten, Eline G M van Geffen, Martijn W H Leenders, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 7, 2018
Influence of Conversion and Anastomotic Leakage on Survival in Rectal Cancer Surgery; Retrospective Cross-sectional StudyEdgar J B Furnée, Tjeerd S Aukema, Steven J Oosterling, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2010
Is 18F-FDG PET/CT useful for the early prediction of histopathologic response to neoadjuvant erlotinib in patients with non-small cell lung cancer?Tjeerd S Aukema, Ingrid Kappers, Renato A Valdés Olmos, et al.
Annals of Surgical Oncology|April 28, 2010
Utility of preoperative 18F-FDG PET/CT and brain MRI in melanoma patients with palpable lymph node metastasesTjeerd S Aukema, Renato A Valdés Olmos, Michel W J M Wouters, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 10, 2014
Timing of metabolic response monitoring during erlotinib treatment in non-small cell lung cancerMatthijs H van Gool, Tjeerd S Aukema, Eva E Schaake, et al.
Annals of Nuclear Medicine|March 11, 2016
Prognostic value of pre-operative glucose-corrected maximum standardized uptake value in patients with non-small cell lung cancer after complete surgical resection and 5-year follow-upRenske Konings, Matthijs H van Gool, Martin P L Bard, et al.
Annals of Surgical Oncology|February 13, 2010
Utility of FDG PET/CT and brain MRI in melanoma patients with increased serum S-100B level during follow-upTjeerd S Aukema, Renato A Valdés Olmos, Catharina M Korse, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 19, 2009
Evaluation of (18)F-FDG PET-CT for differentiation of pulmonary pathology in an approach of outpatient fast track assessmentTjeerd S Aukema, Renato A Valdés Olmos, Houke M Klomp, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 5, 2010
Feasibility of FDG PET/CT to monitor the response of axillary lymph node metastases to neoadjuvant chemotherapy in breast cancer patientsMarieke E Straver, Tjeerd S Aukema, Renato A Valdes Olmos, et al.
European Journal of Cancer (Oxford, England : 1990)|August 20, 2010
Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II-III breast cancerTjeerd S Aukema, Marieke E Straver, Marie-Jeanne T F D Vrancken Peeters, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Clinical Colorectal Cancer|October 10, 2025
Incidence of Mismatch Repair Deficiency in Rectal Cancer and Response to Neoadjuvant TreatmentJelle A Nieuwstraten, Eline G M van Geffen, Martijn W H Leenders, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 7, 2018
Influence of Conversion and Anastomotic Leakage on Survival in Rectal Cancer Surgery; Retrospective Cross-sectional StudyEdgar J B Furnée, Tjeerd S Aukema, Steven J Oosterling, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2010
Is 18F-FDG PET/CT useful for the early prediction of histopathologic response to neoadjuvant erlotinib in patients with non-small cell lung cancer?Tjeerd S Aukema, Ingrid Kappers, Renato A Valdés Olmos, et al.
Annals of Surgical Oncology|April 28, 2010
Utility of preoperative 18F-FDG PET/CT and brain MRI in melanoma patients with palpable lymph node metastasesTjeerd S Aukema, Renato A Valdés Olmos, Michel W J M Wouters, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 10, 2014
Timing of metabolic response monitoring during erlotinib treatment in non-small cell lung cancerMatthijs H van Gool, Tjeerd S Aukema, Eva E Schaake, et al.
Annals of Nuclear Medicine|March 11, 2016
Prognostic value of pre-operative glucose-corrected maximum standardized uptake value in patients with non-small cell lung cancer after complete surgical resection and 5-year follow-upRenske Konings, Matthijs H van Gool, Martin P L Bard, et al.
Annals of Surgical Oncology|February 13, 2010
Utility of FDG PET/CT and brain MRI in melanoma patients with increased serum S-100B level during follow-upTjeerd S Aukema, Renato A Valdés Olmos, Catharina M Korse, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 19, 2009
Evaluation of (18)F-FDG PET-CT for differentiation of pulmonary pathology in an approach of outpatient fast track assessmentTjeerd S Aukema, Renato A Valdés Olmos, Houke M Klomp, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 5, 2010
Feasibility of FDG PET/CT to monitor the response of axillary lymph node metastases to neoadjuvant chemotherapy in breast cancer patientsMarieke E Straver, Tjeerd S Aukema, Renato A Valdes Olmos, et al.
European Journal of Cancer (Oxford, England : 1990)|August 20, 2010
Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II-III breast cancerTjeerd S Aukema, Marieke E Straver, Marie-Jeanne T F D Vrancken Peeters, et al.
Pageof 3